Despite its potential, 3D printing in epidemiology faces several challenges:
Regulatory Hurdles: The production of medical devices using 3D printing must comply with stringent regulatory standards to ensure safety and efficacy. This can slow down the implementation of 3D printed solutions in clinical settings. Material Limitations: The materials used in 3D printing need to be biocompatible and durable, particularly for medical applications. Current materials may not always meet these requirements, limiting the scope of 3D printing in certain areas. Cost and Accessibility: While the cost of 3D printers has decreased over the years, high-quality machines and materials can still be expensive. Ensuring widespread access to this technology, especially in low-resource settings, remains a challenge.
